TD Capital Management’s CAS Medical Systems, Inc. CASM Stock Holding History

TD Capital Management’s Portfolio CASM Stock Details CASM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-38,175	Closed	-$48K	–	197
2018 Q1	$48K	Hold	38,175	–	–	0.01%	83
2017 Q4	$29K	Hold	38,175	–	–	0.01%	90
2017 Q3	$35K	Hold	38,175	–	–	0.01%	84
2017 Q2	$44K	Hold	38,175	–	–	0.01%	77
2017 Q1	$55K	Buy	38,175 +8,746	+30%	+$13.3K	0.02%	72
2016 Q4	$47K	Hold	29,429	–	–	0.01%	73
2016 Q3	$51K	Hold	29,429	–	–	0.02%	68
2016 Q2	$54K	Hold	29,429	–	–	0.02%	69
2016 Q1	$42K	Hold	29,429	–	–	0.01%	74
2015 Q4	$52K	Hold	29,429	–	–	0.02%	67
2015 Q3	$37K	Hold	29,429	–	–	0.01%	83
2015 Q2	$38K	Hold	29,429	–	–	0.01%	93
2015 Q1	$39K	Hold	29,429	–	–	0.01%	94
2014 Q4	$49K	Hold	29,429	–	–	0.01%	91
2014 Q3	$57K	Hold	29,429	–	–	0.01%	86
2014 Q2	$59K	Hold	29,429	–	–	0.01%	82
2014 Q1	$64K	Hold	29,429	–	–	0.01%	78
2013 Q4	$50K	Buy	+29,429	New	+$45.9K	0.01%	78

Other funds holding CASM

ACP

Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Penbrook Management New York $132M AUM 29.91% 1-Year Est. Return

CRC

Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return

TD Capital Management's CASM Position: Q2 2018 in Review

TD Capital Management sold out of CAS Medical Systems, Inc. (CASM) in Q2 2018, closing a stake of 38,175 shares — an estimated $48K sold.

TD Capital Management first reported a position in CASM in Q4 2013 and held it in 18 quarters. The position peaked at $64K in Q1 2014. 21 funds tracked by Wall St. Rank hold CASM as of Q2 2018.

TD Capital Management reported no remaining CAS Medical Systems, Inc. position as of Q2 2018 after selling out during the quarter.
TD Capital Management sold 38,175 CAS Medical Systems, Inc. shares in Q2 2018, an estimated $48K.
TD Capital Management first reported a position in CAS Medical Systems, Inc. in Q4 2013 and held it in 18 quarters.
TD Capital Management's CAS Medical Systems, Inc. position peaked at $64K in Q1 2014.
21 funds tracked by Wall St. Rank held CAS Medical Systems, Inc. as of Q2 2018.

Based on TD Capital Management's 13F filing for Q2 2018, filed 7 Aug 2018.